Pharmaceutical Executive Europe - October 2008 - (Page EC3) Turkey. In the last decade, Turkey has unified its social security system, implemented critical patent legislation (1995), and created new laws for generics registration (1996), reference pricing (2004) and data exclusivity (2005). Astute alliances In 2000 when the Menarini Group, Italy’s largest drug maker, purchased I.E. Ulagay, Turkey’s first medicine company, the deal was viewed with extreme scepticism. However, I.E. Ulagay increased its value by $200 million in 7 years. A spate of strategic partnerships followed: the takeover of Fako by Icelandic company Actavis (2004); the acquisition of Deva by EastPharma (2007); the co-purchase of Turkish player Biofarma by Citigroup and Pils (2006); and the highly touted deal between Zentiva and Eczaclbasl (2007). In that last agreement, the Czech pharma giant took a 75% stake in the Turkish pioneer’s generics division, a move that not only symbolized the attractiveness of the market, but also the ease that multinationals have had in imposing themselves on a burgeoning sector. Six international companies rank among the industry’s top 10 sellers, including market leader Novartis ($800 million), Sanofi Aventis (nearly $600 million) and GlaxoSmithKline (about $450 million). With broad product portfolios, deep prescription drug pipelines and economies of scale, multinationals have quickly asserted their dominance. Challenges and opportunities Turkish companies are also prospering. Eighty-five local manufacturers, many with family roots and post-World www.pharmexeceurope.com 3 http://www.pharmexeceurope.com
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Europe - October 2008 Pharmaceutical Executive Europe - October 2008 Contents News and Analysis Calendar BioFutures Strategy Fundamentals Executive Recruitment: Small Company, Big Career Executive Recruitment: Instant Pharma Named Patient Programmes Executive Review: Turkey Pharmaceutical Executive Europe - October 2008 Pharmaceutical Executive Europe - October 2008 - Pharmaceutical Executive Europe - October 2008 (Page 1) Pharmaceutical Executive Europe - October 2008 - Contents (Page 2) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 3) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 4) Pharmaceutical Executive Europe - October 2008 - News and Analysis (Page 5) Pharmaceutical Executive Europe - October 2008 - Calendar (Page 6) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 7) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 8) Pharmaceutical Executive Europe - October 2008 - BioFutures (Page 9) Pharmaceutical Executive Europe - October 2008 - Strategy Fundamentals (Page 10) Pharmaceutical Executive Europe - October 2008 - Strategy Fundamentals (Page 11) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 12) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 13) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Small Company, Big Career (Page 14) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 15) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 16) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 17) Pharmaceutical Executive Europe - October 2008 - Executive Recruitment: Instant Pharma (Page 18) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 19) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 20) Pharmaceutical Executive Europe - October 2008 - Named Patient Programmes (Page 21) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 22) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 23) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 24) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 25) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 26) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 27) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 28) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 29) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 30) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 31) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 32) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 33) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 34) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 35) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 36) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page 37) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC1) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC2) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC3) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC4) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC5) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC6) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC7) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC8) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC9) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC10) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC11) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC12) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC13) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC14) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC15) Pharmaceutical Executive Europe - October 2008 - Executive Review: Turkey (Page EC16)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.